Cargando…

CDCA8 Contributes to the Development and Progression of Thyroid Cancer through Regulating CDK1

Background: This study aims to reveal regulatory role of cell division cycle associated 8 (CDCA8) in thyroid cancer progression and metastasis. Methods: A series of experiments in vivo and in vitro were performed to explore the function of CDCA8 in thyroid cancer. Results: Immunohistochemical analys...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiang, Cheng, Sun, Wu-hui, Ke, You, Yu, Xing, Wang, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066215/ https://www.ncbi.nlm.nih.gov/pubmed/35517403 http://dx.doi.org/10.7150/jca.64747

Ejemplares similares

Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient
por: Phan, Nam Nhut, et al.
Publicado: (2018)

Borealin/CDCA8 deficiency alters thyroid development and results in papillary tumor-like structures
por: Didier-Mathon, Hortense, et al.
Publicado: (2023)

Overexpression of CDCA8 promotes the malignant progression of cutaneous melanoma and leads to poor prognosis
por: Ci, Chao, et al.
Publicado: (2019)

CDCA5 promotes the progression of breast cancer and serves as a potential prognostic biomarker
por: Hu, Hao, et al.
Publicado: (2022)

CDCA8 induced by NF-YA promotes hepatocellular carcinoma progression by regulating the MEK/ERK pathway
por: Chen, Erbao, et al.
Publicado: (2023)

CDCA1/2/3/5/7/8 as novel prognostic biomarkers and CDCA4/6 as potential targets for gastric cancer
por: Li, Zhaoxing, et al.
Publicado: (2021)

TMED3 promotes the development of malignant melanoma by targeting CDCA8 and regulating PI3K/Akt pathway
por: Guo, Xianling, et al.
Publicado: (2023)

Cyclin-Dependent Kinase 1 (CDK1) is Co-Expressed with CDCA5: Their Functions in Gastric Cancer Cell Line MGC-803
por: Huang, Zhigang, et al.
Publicado: (2020)

CDCA8 expression and its clinical relevance in patients with bladder cancer
por: Bi, Yaqiong, et al.
Publicado: (2018)

CDCA8 as an independent predictor for a poor prognosis in liver cancer
por: Shuai, Yu, et al.
Publicado: (2021)

SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway
por: Luo, Zhenzhen, et al.
Publicado: (2021)

CDCA7 Facilitates Tumor Progression by Directly Regulating CCNA2 Expression in Esophageal Squamous Cell Carcinoma
por: Li, Hongyi, et al.
Publicado: (2021)

MiR-497-5p down-regulates CDCA4 to restrains lung squamous cell carcinoma progression
por: Hu, Jiangwei, et al.
Publicado: (2021)

Knockdown of CDCA8 inhibits the proliferation and enhances the apoptosis of bladder cancer cells
por: Gao, Xin, et al.
Publicado: (2020)

CDCA3 Predicts Poor Prognosis and Affects CD8(+) T Cell Infiltration in Renal Cell Carcinoma
por: Bai, Yuanyuan, et al.
Publicado: (2022)

Knockdown of CDCA5 suppresses malignant progression of breast cancer cells by regulating PDS5A
por: Wang, Yang, et al.
Publicado: (2022)

KIF22 promotes bladder cancer progression by activating the expression of CDCA3
por: Li, Kai, et al.
Publicado: (2021)

CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway
por: Ji, Junpeng, et al.
Publicado: (2021)

CDK12 promotes papillary thyroid cancer progression through regulating the c-myc/β-catenin pathway
por: Bai, Ning, et al.
Publicado: (2020)

The histone variant macroH2A suppresses melanoma progression through regulation of CDK8
por: Kapoor, Avnish, et al.
Publicado: (2010)

The role of the CDCA gene family in ovarian cancer
por: Chen, Chongxiang, et al.
Publicado: (2020)

[Corrigendum] CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway
por: Ji, Junpeng, et al.
Publicado: (2023)

[Retracted] KIF22 promotes bladder cancer progression by activating the expression of CDCA3
por: Li, Kai, et al.
Publicado: (2023)

Knockdown of PSMC2 contributes to suppression of cholangiocarcinoma development by regulating CDK1
por: Duan, Xiaohui, et al.
Publicado: (2021)

Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma
por: Liu, Yuenan, et al.
Publicado: (2020)

Overexpression of CDCA8 Predicts Poor Prognosis and Promotes Tumor Cell Growth in Prostate Cancer
por: Wan, Shun, et al.
Publicado: (2022)

Identification of CDCA8, DSN1 and BIRC5 in Regulating Cell Cycle and Apoptosis in Osteosarcoma Using Bioinformatics and Cell Biology
por: Li, Qinwen, et al.
Publicado: (2020)

Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma
por: Wang, Jianlin, et al.
Publicado: (2018)

High expression of CDCA7 predicts tumor progression and poor prognosis in human colorectal cancer
por: Li, Siman, et al.
Publicado: (2020)

Comprehensive Analysis of Aerobic Exercise-Related Genes Identifies CDCA4 That Promotes the Progression of Osteosarcoma
por: Hao, Suyu, et al.
Publicado: (2021)

CDCA7L promotes glioma proliferation by targeting CCND1 and predicts an unfavorable prognosis
por: Ji, Qian-Kun, et al.
Publicado: (2019)

CDCA2 promotes tumorigenesis and induces radioresistance in oesophageal squamous cell carcinoma cells
por: Xu, Bing, et al.
Publicado: (2021)

Double-targeting CDCA8 and E2F1 inhibits the growth and migration of malignant glioma
por: Wang, Xiaoxiong, et al.
Publicado: (2021)

CDCA8 promotes bladder cancer survival by stabilizing HIF1α expression under hypoxia
por: Zhou, Qiang, et al.
Publicado: (2023)

CDCA2 Inhibits Apoptosis and Promotes Cell Proliferation in Prostate Cancer and Is Directly Regulated by HIF-1α Pathway
por: Zhang, Yixiang, et al.
Publicado: (2020)

CDCA7 is a critical mediator of lymphomagenesis that selectively regulates anchorage-independent growth
por: Jiménez-P, Raúl, et al.
Publicado: (2018)

Prognostic and Immunological Roles of Cell Cycle Regulator CDCA5 in Human Solid Tumors
por: He, Jing, et al.
Publicado: (2022)

CDCA2 Promotes HCC Cells Development via AKT–mTOR Pathway
por: Li, Kai, et al.
Publicado: (2022)

DPP3/CDK1 contributes to the progression of colorectal cancer through regulating cell proliferation, cell apoptosis, and cell migration
por: Tong, Yixin, et al.
Publicado: (2021)

Circ_0001421 facilitates glycolysis and lung cancer development by regulating miR-4677-3p/CDCA3
por: Zhang, Koudong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j220cvh9ugnclbuscbluoqvcb4